WJWilmar M. T. Jolink

Wilmar M. T. Jolink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wilmar M. T. Jolink has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cortical Cerebral Microinfarcts in Spontaneous Intracerebral Hemorrhage on 3T and 7T MRI

    by Wilmar M.T. Jolink, Susanne J. van Veluw, Doeschka A. Ferro, Kim Wiegertjes, Ingeborg Rasing, Jeroen Hendrikse, Marianne A.A. van Walderveen, Gabriel J.E. Rinkel, Marieke J.H. Wermer, Floris H.B.M. Schreuder, et al.

    MRI markers of cerebral small vessel disease (cSVD) in patients with spontaneous intracerebral hemorrhage (sICH) have provided insight in the underlying vascular pathology. Cortical cerebral microinfarcts (CMIs) are a relatively novel marker of cSVD. We aimed to assess presence and location within the cortex of CMIs in patients with sICH on 3T and 7T MRI, and to determine their association with hematoma location and other neuroimaging markers of cSVD. From a multicenter prospective observational cohort study, we included consecutive adult patients who underwent 3T and/or 7T MRI within 3 months after sICH. We determined presence and location of CMIs within the cortex (superficial or deeper layers; on 7T MRI) and assessed associations between presence of cortical CMIs and vascular risk factors, hematoma location, and other MRI markers of cSVD with multiple regression analyses. We included 135 patients (mean age 63 years; 30% female). On 3T MRIs, we found 100 cortical CMIs in 57 patients (42%, median number 2, interquartile range [IQR] 1-3; lobar ICH 24 of 58 patients [41%]; non-lobar ICH 33 of 77 patients [43%]). On 7T MRI images, we found 59 cortical CMIs in 28 of 40 patients (70%; median number of 2, IQR 1-3; lobar ICH 8 of 12 patients [67%]; non-lobar ICH 20 of 28 patients [71%]). Presence of cortical CMIs was associated with history of TIA/ischemic stroke (relative risk [RR] 2.7, 95% CI 1.1-6.4), but not with other vascular risk factors or any of the MRI markers of cSVD. On 7T MRI, CMIs were located in the superficial part of the cortex in 30% of patients with lobar vs 5% of patients with non-lobar ICH (RR 2.7, 95% CI 1.5-5.0). Cortical CMIs are a common finding in patients with sICH on both 3T and 7T MRIs with a similar frequency in patients with lobar and non-lobar sICH. Patients with lobar sICH, more often have CMIs in the superficial part of the cortex than those with non-lobar sICH. Location of CMIs within the cortex might provide insight into the underlying type of small vessel disease in sICH.


  • Top Cited Papers

    Intracerebral haemorrhage — mechanisms, diagnosis and prospects for treatment and prevention

    by David J. Seiffge, Simon Fandler-Höfler, Yang Du, Martina B. Goeldlin, Wilmar M. T. Jolink, Catharina J. M. Klijn, David J. Werring

    Intracerebral haemorrhage (ICH) is a devastating condition associated with high mortality and substantial residual disability among survivors. Effective treatments for the acute stages of ICH are limited. However, promising findings from randomized trials of therapeutic strategies, including acute care bundles that target anticoagulation therapies, blood pressure control and other physiological parameters, and trials of minimally invasive neurosurgical procedures have led to renewed optimism that patient outcomes can be improved. Currently ongoing areas of research for acute treatment include anti-inflammatory and haemostatic treatments. The implementation of effective secondary prevention strategies requires an understanding of the aetiology of ICH, which involves vascular and brain parenchymal imaging; the use of neuroimaging markers of cerebral small vessel disease improves classification with prognostic relevance. Other data underline the importance of preventing not only recurrent ICH but also ischaemic stroke and cardiovascular events in survivors of ICH. Ongoing and planned randomized controlled trials will assess the efficacy of prevention strategies, including antiplatelet agents, oral anticoagulants or left atrial appendage occlusion (in patients with concomitant atrial fibrillation), and optimal management of long-term blood pressure and statin use. Together, these advances herald a new era of improved understanding and effective interventions to reduce the burden of ICH.


  • Open Access

    Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study

    by Jasper R. Senff, Sanjula D. Singh, Marco Pasi, Wilmar M.T. Jolink, Mark A. Rodrigues, Floris H.B.M. Schreuder, Julie Staals, Tobien Schreuder, Jules P.J. Douwes, Jelmer Talsma, et al.

    BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) in the cerebellum has a poor short-term prognosis, whereas data on the long-term case fatality and recurrent vascular events are sparse. Herewith, we aimed to assess the long-term case fatality and recurrence rate of vascular events after a first cerebellar ICH. METHODS: In this international cohort study, we included patients from 10 hospitals (the United States and Europe from 1997 to 2017) aged ≥18 years with a first spontaneous cerebellar ICH who were discharged alive. Data on long-term case fatality and recurrence of vascular events (recurrent ICH [supratentoria or infratentorial], ischemic stroke, myocardial infarction, or major vascular surgery) were collected for survival analysis and absolute event rate calculation. RESULTS: We included 405 patients with cerebellar ICH (mean age [SD], 72 [13] years, 49% female). The median survival time was 67 months (interquartile range, 23–100 months), with a cumulative survival rate of 34% at 10-year follow-up (median follow-up time per center ranged: 15–80 months). In the 347 patients with data on vascular events 92 events occurred in 78 patients, after initial cerebellar ICH: 31 (8.9%) patients had a recurrent ICH (absolute event rate, 1.8 per 100 patient-years [95% CI, 1.2–2.6]), 39 (11%) had an ischemic stroke (absolute event rate, 2.3 [95% CI, 1.6–3.2]), 13 (3.7%) had a myocardial infarction (absolute event rate, 0.8 [95% CI, 0.4–1.3]), and 5 (1.4%) underwent major vascular surgery (absolute event rate, 0.3 [95% CI, 0.1–0.7]). The median time to a first vascular event during follow-up was 27 months (interquartile range, 8.7–50 months), with a cumulative hazard of 47% at 10 years. CONCLUSIONS: The long-term prognosis of patients who survive a first spontaneous cerebellar ICH is poor and comparable to that of patients who survive a first supratentorial ICH. Further identification of patients at high risk of vascular events following the initial cerebellar ICH is needed. Including patients with cerebellar ICH in randomized controlled trials on secondary prevention of patients with ICH is warranted.


  • Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study

    by Ellis S. van Etten, Kanishk Kaushik, Wilmar M.T. Jolink, Emma A. Koemans, Merel S. Ekker, Ingeborg Rasing, Sabine Voigt, Floris H.B.M. Schreuder, Suzanne C. Cannegieter, Gabriël J.E. Rinkel, et al.

    Background: Whether certain activities can trigger spontaneous intracerebral hemorrhage (ICH) remains unknown. Insights into factors that trigger vessel rupture resulting in ICH improves knowledge on the pathophysiology of ICH. We assessed potential trigger factors and their risk for ICH onset. Methods: We included consecutive patients diagnosed with ICH between July 1, 2013, and December 31, 2019. We interviewed patients on their exposure to 12 potential trigger factors (eg, Valsalva maneuvers) in the (hazard) period soon before onset of ICH and their normal exposure to these trigger factors in the year before the ICH. We used the case-crossover design to calculate relative risks (RR) for potential trigger factors. Results: We interviewed 149 patients (mean age 64, 66% male) with ICH. Sixty-seven (45%) had a lobar hemorrhage, 60 (40%) had a deep hemorrhage, 19 (13%) had a cerebellar hemorrhage, and 3 (2%) had an intraventricular hemorrhage. For ICH in general, there was an increased risk within an hour after caffeine consumption (RR=2.5 [95% CI=1.8–3.6]), within an hour after coffee consumption alone (RR=4.8 [95% CI=3.3–6.9]), within an hour after lifting >25 kg (RR=6.6 [95% CI=2.2–19.9]), within an hour after minor head trauma (RR=10.1 [95% CI=1.7–60.2]), within an hour after sexual activity (RR=30.4 [95% CI=16.8–55.0]), within an hour after straining for defecation (RR=37.6 [95% CI=22.4–63.4]), and within an hour after vigorous exercise (RR=21.8 [95% CI=12.6–37.8]). Within 24 hours after flu-like disease or fever, the risk for ICH was also increased (RR=50.7 [95% CI=27.1–95.1]). Within an hour after Valsalva maneuvers, the RR for deep ICH was 3.5 (95% CI=1.7–6.9) and for lobar ICH the RR was 2.0 (95% CI=0.9–4.2). Conclusions: We identified one infection and several blood pressure related trigger factors for ICH onset, providing new insights into the pathophysiology of vessel rupture resulting in ICH.


  • Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

    by Emma A. Koemans, Sabine Voigt, Ingeborg Rasing, Thijs W. van Harten, Wilmar M.T. Jolink, Floris H.B.M. Schreuder, Erik W. van Zwet, Mark A. van Buchem, Matthias J.P. van Osch, Gisela M. Terwindt, et al.

    Background and Purpose: Although evidence accumulates that the cerebellum is involved in cerebral amyloid angiopathy (CAA), cerebellar superficial siderosis is not considered to be a disease marker. The objective of this study is to investigate cerebellar superficial siderosis frequency and its relation to hemorrhagic magnetic resonance imaging markers in patients with sporadic and Dutch-type hereditary CAA and patients with deep perforating arteriopathy–related intracerebral hemorrhage. Methods: We recruited patients from 3 prospective 3 Tesla magnetic resonance imaging studies and scored siderosis and hemorrhages. Cerebellar siderosis was identified as hypointense linear signal loss (black) on susceptibility-weighted or T2*-weighted magnetic resonance imaging which follows at least one folia of the cerebellar cortex (including the vermis). Results: We included 50 subjects with Dutch-type hereditary CAA, (mean age 50 years), 45 with sporadic CAA (mean age 72 years), and 43 patients with deep perforating arteriopathy–related intracerebral hemorrhage (mean age 54 years). Cerebellar superficial siderosis was present in 5 out of 50 (10% [95% CI, 2–18]) patients with Dutch-type hereditary CAA, 4/45 (9% [95% CI, 1–17]) patients with sporadic CAA, and 0 out of 43 (0% [95% CI, 0–8]) patients with deep perforating arteriopathy–related intracerebral hemorrhage. Patients with cerebellar superficial siderosis had more supratentorial lobar (median number 9 versus 2, relative risk, 2.9 [95% CI, 2.5–3.4]) and superficial cerebellar macrobleeds (median number 2 versus 0, relative risk, 20.3 [95% CI, 8.6–47.6]) compared with patients without the marker. The frequency of cortical superficial siderosis and superficial cerebellar microbleeds was comparable. Conclusions: We conclude that cerebellar superficial siderosis might be a novel marker for CAA.


  • Location-specific risk factors for intracerebral hemorrhage

    by Wilmar M.T. Jolink, Kim Wiegertjes, Gabriël J.E. Rinkel, Ale Algra, Frank-Erik de Leeuw, Catharina J.M. Klijn

    Objective: To conduct a systematic review and meta-analysis of studies reporting on risk factors according to the location of the intracerebral hemorrhage. Methods: We searched PubMed and Embase for cohort and case-control studies reporting on ≥100 patients with spontaneous intracerebral hemorrhage, that specified the location of the hematoma and reported associations with risk factors published until June 27th 2019. Two authors independently extracted data on risk factors. Estimates were pooled with the generic variance-based random effects method. Results: After screening 10 013 articles, we included 42 studies totaling 26 174 patients with intracerebral hemorrhage (9 141 lobar and 17 033 non-lobar). Risk factors for non-lobar intracerebral hemorrhage were hypertension (risk ratio 4.25, 95% confidence interval 3.05-5.91, I2=92%), diabetes (RR 1.35, 1.11-1.64, I2=37% ), male sex (RR 1.63, 1.25-2.14, I2=61%), alcohol overuse (RR 1.48, 1.21-1.81, I2=19%), underweight (RR 2.12, 1.12-4.01, I2=31%), and being black (RR 2.19, 1.21-3.96, I2=96%) or Hispanic (RR 2.13,0.94-4.81, I2=71%) in comparison with being white. Hypertension, but not any of the other risk factors, was also a risk factor for lobar intracerebral hemorrhage (RR 1.83, 1.39-2.42, I2=76%). Smoking, hypercholesterolemia and obesity were associated with neither non-lobar nor lobar intracerebral hemorrhage. Conclusions: Hypertension is a risk factor for both non-lobar and lobar intracerebral hemorrhage, although with double the effect for non-lobar intracerebral hemorrhage. Diabetes, male sex, alcohol overuse, underweight, and being black or Hispanic are risk factors for non-lobar intracerebral hemorrhage only. Hence, the term “hypertensive intracerebral hemorrhage” for non-lobar intracerebral hemorrhage is not appropriate.


  • Open Access

    Contrast leakage distant from the hematoma in patients with spontaneous ICH: A 7 T MRI study

    by Wilmar Mt Jolink, Arjen Lindenholz, Ellis S van Etten, Koen M van Nieuwenhuizen, Floris Hbm Schreuder, Hugo J Kuijf, Matthias Jp van Osch, Jeroen Hendrikse, Gabriel Je Rinkel, Marieke Jh Wermer, et al.

    Disruption of the blood–brain barrier (BBB) might play a role in the pathophysiology of cerebral small vessel disease-related ICH. The aim of this study was to assess presence and extent of contrast agent leakage distant from the hematoma as a marker of BBB disruption in patients with spontaneous ICH. We prospectively performed 7 tesla MRI in adult patients with spontaneous ICH and assessed contrast leakage distant from the hematoma on 3D FLAIR images. Thirty-one patients were included (mean age 60 years, 29% women). Median time between ICH and MRI was 20 days (IQR 9–67 days). Seventeen patients (54%; seven lobar, nine deep, one infratentorial ICH) had contrast leakage, located cortical in 16 and cortical and deep in one patient. Patients with contrast leakage more often had lobar cerebral microbleeds (CMBs; 77%) than those without (36%; RR 2.5, 95% CI 1.1–5.7) and a higher number of lobar CMBs (patients with contrast leakage: median 2, IQR 1–8 versus those without: median 0, IQR 0–2; p = 0.02). This study shows that contrast leakage distant from the hematoma is common in days to weeks after spontaneous ICH. It is located predominantly cortical and related to lobar CMBs and therefore possibly to cerebral amyloid angiopathy.


  • Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage

    by Wilmar M.T. Jolink, Catharina J.M. Klijn, Paul J.A.M. Brouwers, L. Jaap Kappelle, Ilonca Vaartjes

    Objective: To assess age- and sex-specific trends in incidence and 30-day and 1-year case fatality of intracerebral hemorrhage (ICH) in the Netherlands. Methods: Patients hospitalized for first ICH were identified through linkage of the national hospital discharge register and population register using ICD-9 code 431. We identified out-of-hospital deaths in the national cause of death register. Incidence, 30-day and 1-year case fatality, and total mortality rate were calculated by age and sex. We identified time trends by joinpoint regression analysis and Mann-Kendall tests. Results: We identified 41,068 cases of ICH (51% men) between 1998 and 2010, of which 6% were out-of-hospital deaths. ICH incidence declined in men and women younger than 75 years (p ≤ 0.01, not significantly in men 35–54 years) but remained stable in patients 75 years and older. Thirty-day and 1-year case fatality declined in patients younger than 75 years (not significantly in women 35–54 years). In patients aged 35 to 54 years, ICH mortality remained stable until 2003 and then declined slightly (annual percentage change [APC] men: −7.09%; 95% confidence interval [CI] −11.39 to −2.59; women: −8.67%; 95% CI −15.18 to −1.66). In patients 55 to 74 years, mortality declined in men between 1995 and 2010 (APC −4.55%; 95% CI −5.49 to −3.59) and in women between 1992 and 2010 (APC −3.51%; 95% CI −4.16 to −2.85). Mortality did not decline in patients aged 75 years and older. Conclusion: In the Netherlands, ICH incidence, case fatality, and mortality rates have declined significantly in men and women younger than 75 years but remained stable in patients 75 years and older. The observed time trends may be explained by better prevention and treatment during the previous 2 decades of which the elderly do not seem to benefit.


  • Open Access

    Outcome after intracranial haemorrhage from dural arteriovenous fistulae; a systematic review and case-series

    by W. M. T. Jolink, J. M. C. van Dijk, C. J. J. van Asch, G. A. P. de Kort, A. Algra, R. J. M. Groen, G. J. E. Rinkel, C. J. M. Klijn

    Dural arteriovenous fistulae (DAVFs) are a rare cause of intracranial haemorrhage. We aimed to investigate outcome of patients with intracranial haemorrhage from a DAVF. We performed a systematic literature search for studies reporting outcome after intracranial haemorrhage caused by a DAVF. We used predefined selection criteria and assessed the quality of the studies. In addition, we studied outcome in all patients with DAVF who had presented with intracranial haemorrhage at two university centers in the Netherlands, between January 2007 and April 2012. We calculated case fatality and proportions of patients with poor outcome (defined as modified Rankin Scale ≥ 3 or Glasgow Outcome Scale ≤ 3) during follow-up. We investigated mean age, sex, mid-year of study and percentage of patients with parenchymal haemorrhage as determinants of case fatality and poor outcome. The literature search yielded 16 studies, all but two retrospective and all hospital-based. Combined with our cohort of 29 patients the total number of patients with DAVF-related intracranial haemorrhage was 326 (58 % intracerebral haemorrhage). At a median follow-up of 12 months case fatality was 4.7 % (95 % CI 2.5–7.5; 17 cohorts) and the proportion of patients with poor outcome 8.3 % (95 % CI 3.1–15.7; nine cohorts). We found no effect of mean age, sex, mid-year of the cohorts and percentage of patients with parenchymal haemorrhage on either outcome. Hospital based case-series suggest a relatively low risk of death and poor outcome in patients with intracranial haemorrhage due to rupture of a DAVF. These risks may be underestimated because of bias.


  • Transcranial Doppler Ultrasonography CO2 Reactivity Does Not Predict Recurrent Ischaemic Stroke in Patients with Symptomatic Carotid Artery Occlusion

    by Wilmar M.T. Jolink, Rutger Heinen, Suzanne Persoon, Albert van der Zwan, L. Jaap Kappelle, Catharina J.M. Klijn

    Background: Patients with transient ischaemic attacks (TIAs) or minor disabling ischaemic stroke associated with an internal carotid artery (ICA) occlusion have a high risk of recurrent stroke in case of compromised cerebral blood flow. Recent studies showed that increased oxygen extraction fraction measured by positron emission tomography (PET) is still an independent predictor of subsequent stroke under current medical treatment, but PET facilities are not widely available. Transcranial Doppler (TCD) ultrasonography CO2 reactivity is a cheap and non-invasive alternative to measure haemodynamic compromise. The aim of our study was to investigate whether TCD CO2 reactivity is an independent predictor of recurrent ischaemic stroke in a large cohort of patients with symptomatic ICA occlusion in a time where rigorous control of vascular risk factors has been widely implemented in clinical practice. Methods: Between July 1995 and December 2009, we included consecutive patients with TIAs or minor disabling ischaemic stroke (modified Rankin Scale ≤3) associated with ICA occlusion who were referred to the University Medical Centre Utrecht, The Netherlands. All patients were treated with antiplatelet therapy and received rigorous control of vascular risk factors, including statins, treatment for diabetes and hypertension and lifestyle advices. CO2 reactivity was measured with TCD within 3 months after presentation. We determined the predictive value of TCD CO2 reactivity for recurrent ischaemic stroke using Cox proportional hazard analysis. Results: We included 201 patients with a median follow-up time of 7.1 years. Mean CO2 reactivity was 15% (±20 standard deviation). The annual rate for ipsilateral ischaemic stroke was 2.2% [95% confidence interval (CI) 1.4-3.2] and for any recurrent stroke 3.2% (95% CI 2.3-4.4). We did not find a significant relationship between CO2 reactivity and the risk of ipsilateral [hazard ratio (HR) for every increase in percentage point 1.01, 95% CI 0.99-1.02] or any recurrent ischaemic stroke (HR 1.01, 95% CI 0.998-1.02). Multivariable analysis showed a significant relationship with history of stroke (HR 4.0, 95% CI 1.8-9.0) for ipsilateral recurrent stroke, and age (HR for increase per year 1.05, 95% CI 1.01-1.09) and a history of stroke (HR 3.4, 95% CI 1.7-6.6) for any recurrent stroke. Conclusions: In patients with TIAs or non-disabling stroke associated with occlusion of the carotid artery, the long-term annual risk of stroke is generally low with careful control of vascular risk factors. Impaired CO2 reactivity measured within 3 months after presentation does not identify the subgroup of patients at high risk of recurrent ischaemic stroke.